vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Hyperscale Data, Inc. (GPUS). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $26.9M, roughly 1.7× Hyperscale Data, Inc.). Amarin Corp plc runs the higher net margin — -23.3% vs -112.0%, a 88.7% gap on every dollar of revenue. On growth, Hyperscale Data, Inc. posted the faster year-over-year revenue change (38.4% vs 7.0%). Over the past eight quarters, Hyperscale Data, Inc.'s revenue compounded faster (-16.3% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Hyperscale Data, Inc. provides GPU-accelerated computing infrastructure and cloud solutions tailored for AI development, big data processing, and high-performance computing workloads. It primarily serves AI startups, large technology firms, and cloud service providers across North America and the Asia-Pacific region, delivering scalable, high-efficiency computing resources to support complex data processing needs.

AMRN vs GPUS — Head-to-Head

Bigger by revenue
AMRN
AMRN
1.7× larger
AMRN
$45.1M
$26.9M
GPUS
Growing faster (revenue YoY)
GPUS
GPUS
+31.4% gap
GPUS
38.4%
7.0%
AMRN
Higher net margin
AMRN
AMRN
88.7% more per $
AMRN
-23.3%
-112.0%
GPUS
Faster 2-yr revenue CAGR
GPUS
GPUS
Annualised
GPUS
-16.3%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
GPUS
GPUS
Revenue
$45.1M
$26.9M
Net Profit
$-10.5M
$-30.1M
Gross Margin
14.5%
Operating Margin
35.5%
-117.8%
Net Margin
-23.3%
-112.0%
Revenue YoY
7.0%
38.4%
Net Profit YoY
33.0%
-6670.3%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
GPUS
GPUS
Q1 26
$45.1M
Q4 25
$49.2M
$26.9M
Q3 25
$49.7M
$24.3M
Q2 25
$72.7M
$25.9M
Q1 25
$42.0M
$25.0M
Q4 24
$62.3M
$19.4M
Q3 24
$42.3M
$31.1M
Q2 24
$67.5M
$17.8M
Net Profit
AMRN
AMRN
GPUS
GPUS
Q1 26
$-10.5M
Q4 25
$-1.2M
$-30.1M
Q3 25
$-7.7M
$-13.0M
Q2 25
$-14.1M
$-19.1M
Q1 25
$-15.7M
$-4.2M
Q4 24
$-48.6M
$-445.0K
Q3 24
$-25.1M
$-25.5M
Q2 24
$1.5M
$-33.9M
Gross Margin
AMRN
AMRN
GPUS
GPUS
Q1 26
Q4 25
47.1%
14.5%
Q3 25
44.7%
25.8%
Q2 25
69.2%
23.7%
Q1 25
59.8%
21.1%
Q4 24
-15.4%
6.5%
Q3 24
38.5%
27.5%
Q2 24
63.4%
-21.3%
Operating Margin
AMRN
AMRN
GPUS
GPUS
Q1 26
35.5%
Q4 25
-12.9%
-117.8%
Q3 25
-22.4%
-57.8%
Q2 25
-22.0%
-39.2%
Q1 25
-39.9%
-25.5%
Q4 24
-84.3%
-46.8%
Q3 24
-59.5%
-79.2%
Q2 24
-0.8%
-151.4%
Net Margin
AMRN
AMRN
GPUS
GPUS
Q1 26
-23.3%
Q4 25
-2.5%
-112.0%
Q3 25
-15.6%
-53.5%
Q2 25
-19.4%
-73.7%
Q1 25
-37.4%
-16.8%
Q4 24
-78.0%
-2.3%
Q3 24
-59.4%
-82.3%
Q2 24
2.3%
-190.7%
EPS (diluted)
AMRN
AMRN
GPUS
GPUS
Q1 26
Q4 25
$0.00
Q3 25
$-0.02
$-0.39
Q2 25
$-0.03
$-2.66
Q1 25
$-0.04
Q4 24
$-0.12
$-8.78
Q3 24
$-0.06
$-24.82
Q2 24
$0.00
$-37.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
GPUS
GPUS
Cash + ST InvestmentsLiquidity on hand
$307.8M
$13.1M
Total DebtLower is stronger
$83.1M
Stockholders' EquityBook value
$119.8M
Total Assets
$645.8M
$313.7M
Debt / EquityLower = less leverage
0.69×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
GPUS
GPUS
Q1 26
$307.8M
Q4 25
$302.6M
$13.1M
Q3 25
$286.6M
$24.8M
Q2 25
$298.7M
$5.9M
Q1 25
$281.8M
$4.2M
Q4 24
$294.2M
$4.5M
Q3 24
$305.7M
$7.9M
Q2 24
$306.7M
$9.6M
Total Debt
AMRN
AMRN
GPUS
GPUS
Q1 26
Q4 25
$83.1M
Q3 25
$80.0M
Q2 25
$88.5M
Q1 25
$92.8M
Q4 24
$96.7M
Q3 24
$104.8M
Q2 24
$106.8M
Stockholders' Equity
AMRN
AMRN
GPUS
GPUS
Q1 26
Q4 25
$459.3M
$119.8M
Q3 25
$458.9M
$55.9M
Q2 25
$464.9M
$5.5M
Q1 25
$473.7M
$6.3M
Q4 24
$486.2M
$8.6M
Q3 24
$531.4M
$2.7M
Q2 24
$551.9M
$26.7M
Total Assets
AMRN
AMRN
GPUS
GPUS
Q1 26
$645.8M
Q4 25
$670.8M
$313.7M
Q3 25
$659.8M
$242.4M
Q2 25
$670.1M
$213.5M
Q1 25
$655.7M
$218.5M
Q4 24
$685.3M
$220.8M
Q3 24
$750.6M
$231.5M
Q2 24
$799.9M
$270.8M
Debt / Equity
AMRN
AMRN
GPUS
GPUS
Q1 26
Q4 25
0.69×
Q3 25
1.43×
Q2 25
16.06×
Q1 25
14.71×
Q4 24
11.19×
Q3 24
38.41×
Q2 24
4.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
GPUS
GPUS
Operating Cash FlowLast quarter
$-37.7M
Free Cash FlowOCF − Capex
$-56.2M
FCF MarginFCF / Revenue
-208.7%
Capex IntensityCapex / Revenue
68.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-87.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
GPUS
GPUS
Q1 26
Q4 25
$15.3M
$-37.7M
Q3 25
$-12.7M
$-17.8M
Q2 25
$16.6M
$-3.1M
Q1 25
$-12.5M
$-4.0M
Q4 24
$-13.3M
$-9.2M
Q3 24
$-2.4M
$3.7M
Q2 24
$-2.7M
$-3.7M
Free Cash Flow
AMRN
AMRN
GPUS
GPUS
Q1 26
Q4 25
$-56.2M
Q3 25
$-20.6M
Q2 25
$-3.5M
Q1 25
$-6.8M
Q4 24
$-9.3M
Q3 24
$2.6M
Q2 24
$-5.9M
FCF Margin
AMRN
AMRN
GPUS
GPUS
Q1 26
Q4 25
-208.7%
Q3 25
-84.5%
Q2 25
-13.5%
Q1 25
-27.3%
Q4 24
-47.6%
Q3 24
8.4%
Q2 24
-33.4%
Capex Intensity
AMRN
AMRN
GPUS
GPUS
Q1 26
Q4 25
68.6%
Q3 25
11.5%
Q2 25
1.5%
Q1 25
11.5%
Q4 24
0.3%
Q3 24
3.6%
Q2 24
12.6%
Cash Conversion
AMRN
AMRN
GPUS
GPUS
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

GPUS
GPUS

Transferred Over Time$10.4M39%
Revenue From Mined Crypto Assets At Sentinum Owned And Operated Facilities$5.8M21%
Hotel And Real Estate Operations$4.8M18%
Other$4.0M15%
Turn On Green$2.0M7%

Related Comparisons